Matshi 13-19

Phila Ngcono kwaye Uphile Ixesha Elide

I-GAAPP ijoyine iqela lamaqabane amaninzi achaphazelekayo kumazwe ngamazwe ukubhiyozela iVeki yokuBuyiselwa kwePulmonary kunye nokwazisa ngokubaluleka kokwenza izigulana eziphila neCOPD, iFPI, kunye nezinye iimeko ezingapheliyo zokuphefumla.

Abantu abangaphezu kwezigidi ezili-16 e-US baneCOPD1, ukuya kuthi ga I-60% ayifunyaniswanga.2 I-COPD yeyona nto yesithathu ebangela ukufa kwabantu kwihlabathi liphela.3 I-COPD kunye nesifo se-fibrotic lung esifana ne-idiopathic pulmonary fibrosis (IPF) azikho unyango lwaziwayo kwaye zinxulunyaniswa nokubandezeleka okukhulu kunye neempawu ezikhubazayo. Ukuvuselelwa kwemiphunga (PR) ngumgangatho wokhathalelo lwabantu abaneCOPD kunye ne-IPF kwaye inxulunyaniswa nomsebenzi womzimba ophuculweyo, iimpawu, umoya, kunye nomgangatho wobomi.

Nangona i-PR isekwe kakuhle njengonyango olusebenzayo lweCOPD kunye nezinye izifo ezingapheliyo zokuphefumla,4,5 e-US, kuphela i-3-4% yabaxhamli beMedicare abaneCOPD bafumana i-PR.6 Ngokufanayo, uqikelelo oluphantsi lukho kwihlabathi liphela.7

Idatha ekhulayo iphakamisa enye inzuzo ye-PR: ukunciphisa ukufa. Uphononongo olwenziwa nguLindenauer kunye noogxa bafumanisa ukuba, kubantu ababhedlele ngenxa yokunyanzeliswa kweCOPD, i-PR phakathi kweenyanga ezintathu zokukhupha vs. Kamva okanye akukho PR, yayinxulumene nomngcipheko ophantsi kakhulu wokufa ngonyaka omnye (umlinganiselo wengozi, i-0.63; oko kukuthi, i-37% yengozi ephantsi yokusweleka kunyaka olandela ukukhutshwa).8 Uphononongo lusebenzise idatha yamabango e-197,376 abaxhamli beMedicare abakhutshwe emva kokulaliswa esibhedlele ngenxa yeCOPD. Kubantu abanesifo se-fibrotic interstitial lung (ILD), kuquka i-IPF, uSabina Guler kunye noogxa babonise ukuba abo banophuculo olubalulekileyo ekusebenzeni komthambo (uvavanywe ngumgama wokuhamba wemizuzu emithandathu) kulandela i-PR iphucule ukusinda.

Abo bane-ILD abathathe inxaxheba ubuncinane kwi-80% yeeseshoni ezicwangcisiweyo ze-PR babene-33% yengozi ephantsi yokufa.9 Zombini izifundo ziyaxhasa I-PR njengento ephambili ephambili kubantu abaneCOPD kunye ne-fibrotic ILD.

Izigulane ezine-COPD kunye ne-fibrotic ILD kufuneka zazi ukuba i-PR ayinakho nje ukubanceda ukuba bazive bengcono kwaye bazimele kwaye baphile ixesha elide.

Ileta yesicelo somsebenzi

Imibutho ethatha inxaxheba

Ucaphulo

  1. COPD. Amaziko oLawulo noThintelo lweZifo. Ipapashwe nge-6 Juni, 2018. Ifikeleleke ngoFebruwari 17, 2022. https://www.cdc.gov/copd/index.html
  2. UMartinez C, kunye nabanye. Izifo zemiphunga ezingafunyaniswanga kwi-US Annals ATS. 2015;(12):1788-1795.
  3. https://www.who.int/news-room/fact-sheets/detai!/the-top-10-causes-of-death Accessed February 17, 2022.
  4. Spruit MA, et al; I-ATS/ERS Task Force kwi-Pulmonary Rehabilitation. Isitatimende esisemthethweni se-ATS / ERS: iikhonsepthi eziphambili kunye nenkqubela phambili yokuvuselelwa kwemiphunga. NdinguJ Respir Crit Care Med. 2013;188(8):el3-e64. doi: 10.1164 / rccm.201309- 1634ST
  5. McCarthy B, et al. Ukuvuselelwa kwemiphunga kwiCOPD. I-Cochrane Database Syst Rev. 2015; 2 (2): CD003793. wenza: 10. 1002/14651858.CD003793.pub3
  6. Nishi SP, et al. Ukusetyenziswa kwe-Pulmonary rehabilitation kubantu abadala abadala abaneCOPD, i-2003 ukuya kwi-2012. J Cardiopulm Rehabil Prev. 2016;36(5):375-382. doi: 10.1097 /HCR.0000000000000194
  7. Desveaux L, et al. Uthelekiso lwamazwe ngamazwe lokuvuselelwa kwemiphunga: uphononongo olucwangcisiweyo. COPD. 2015; 12(2): 144-53. doi: 10.3109/15412555.2014.922066
  8. Lindenauer PK, Stefan MS, Pekow PS, et al. Umbutho phakathi kokuqaliswa kokuvuselelwa kwemiphunga emva kokulaliswa esibhedlele kwiCOPD kunye nokusinda kweminyaka eyi-1 phakathi kwabaxhamli beMedicare. JAMA. 2020 Meyi 12;323(18):1813-1823. doi: 10.1001/jama.2020.4437.
  9. Guler SA, Hur SA, Stickland MK, et al. Ukusinda emva kokulaliswa kwesigulana okanye ukuvuselelwa kwemiphunga